Pfizer’s AstraZeneca bid: bitter pill or welcome tonic? – opinion – 30 April 2014 – New Scientist

http://www.newscientist.com/article/dn25485-pfizers-astrazeneca-bid-bitter-pill-or-welcome-tonic.html?utm_source=NSNS&utm_medium=SOC&utm_campaign=twitter&cmpid=SOC%7CNSNS%7C2012-GLOBAL-twitter#.U2DdtdPTXFo

Following on from my previous post, here Sarah Main from New Scientist asks what Pfizer’s takeover bid of Astrazeneca may mean for UK science.

Advertisements
Standard

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s